Squeeze Report — October 14, 2026
Two biotechs with 40%+ short interest — TNGX and CSIQ — frame today's book, but conviction is capped by dilution and cheap borrow. The more interesting tension sits in MMED, where a Medtronic split-off could force a violent, short-lived cover into a float that expands tenfold days later.
Today's top short-squeeze candidates
- #1BKVBKV Corporation80
34% of float sold short · 6.1 days to cover · +0% over 20 days
SI 34%DTC 6.1$24.44+0% 20dEnergy - #2TNGXTango Therapeutics, Inc.78
41.9% short interest meets ESMO pancreatic cancer data on Oct 23 — real fuel, but a $400M ATM keeps shorts comfortable.
SI 42%DTC 12.5$22.22-7% 20dHealthcare - #3IEPIcahn Enterprises, L.P. Common78
Days-to-cover looks extreme at 22, but 51% of a tiny float is only 2.5% of total units — the squeeze math doesn't hold.
SI 51%DTC 22.4$6.71-4% 20dEnergy - #4REPLReplimune Group, Inc. Common S77
29% of float sold short · 10.8 days to cover · -7% over 20 days · options pricing in the 93th percentile (crowded)
SI 29%DTC 10.8$12.11-7% 20dHealthcare - #5ABSIAbsci Corporation Common Stock76
25% of float sold short · 7.5 days to cover · +15% over 20 days
SI 25%DTC 7.5$9.10+15% 20dHealthcare - #6SYMSymbotic Inc. Class A Common S76
Four straight biweekly short increases plus a fresh acquisition, but insider selling and a surviving class action blunt the edge.
SI 35%DTC 10.1$40.89-4% 20dIndustrials - #7ULCCFrontier Group Holdings, Inc.76
24% of float sold short · 9.4 days to cover · +0% over 20 days
SI 24%DTC 9.4$5.58+0% 20dIndustrials - #8IBRXImmunityBio, Inc. Common Stock75
109% of float sold short · 8.9 days to cover · +20% over 20 days · options pricing in the 87th percentile (crowded)
SI 109%DTC 8.9$9.80+20% 20dHealthcare - #9TALTAL Education Group75
40% of float sold short · 6.8 days to cover · +8% over 20 days
SI 40%DTC 6.8$12.64+8% 20dConsumer Defensive - #10CAKECheesecake Factory Incorporate75
22% of float sold short · 7.3 days to cover · +16% over 20 days
SI 22%DTC 7.3$112.37+16% 20dConsumer Cyclical - #11ENOVEnovis Corporation75
Insider buying and rising shorts are a rare pairing, but near-zero options IV says the market isn't bracing for a squeeze.
SI 19%DTC 5.8$18.99+6% 20dHealthcare - #12OMEROmeros Corporation Common Stoc75
FDA-approved YARTEMLEA launch with reimbursement now live, yet shorts are covering, not adding — squeeze mechanics are absent.
SI 16%DTC 7.0$18.88+10% 20dHealthcare - #13GLOBGLOBANT S.A.75
31% of float sold short · 13.2 days to cover · -7% over 20 days · options pricing in the 84th percentile (crowded)
SI 31%DTC 13.2$37.17-7% 20dTechnology - #14TDCTERADATA CORPORATION74
A $430M remaining buyback limits forced covering; shorts are already exiting at a 6% clip.
SI 17%DTC 10.5$30.48+4% 20dTechnology - #15NAMSNewAmsterdam Pharma Company N.74
Shorts added 21.6% into a stock near 52-week lows; a PREVAIL interim read is the only plausible ignition.
SI 24%DTC 9.4$20.19-5% 20dHealthcare
See the full ranked board
This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.
Open the live squeeze board →